Skip to main content
SpringerLink
Log in

Topische und systemische Therapie der Rosazea

  • Chapter
Energie für die Haut

  • 1363 Accesses

Zusammenfassung

Bei der Rosazea handelt es sich um eine der häufigsten Erkrankungen im Erwachsenenalter, wobei jedoch bereits Kinder betroffen sein können. Umgangssprachlich wird diese gutartige Erkrankung auch Kupferfinne oder Couperose genannt. Das klinische Bild ist sehr variabel und reicht von Erythemen, Teleangiektasien, Papeln und Pusteln bis hin zu okulären Veränderungen oder phymatösen, also verdickenden Schwellungen. Da die Symptome meist zentrofazial ausgeprägt sind, besteht bei den meisten Patienten ein großer Leidensdruck mit eingeschränkter Lebensqualität. Bei adäquater Therapie und geeigneter Hautpflege ist eine deutliche Besserung der Symptomatik möglich. Um diese Aspekte und weitere über die Rosazea geht es im vorliegenden Kapitel.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 149.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Akhyani M, Ehsani AH, Ghiasi M, Jafari AK (2008) Comparison of efficacy of azithromycin vs. doxycycline in the treatment of rosacea: a randomized open clinical trial. Int J Dermatol. 47(3):284-8

    Article  CAS  Google Scholar 

  • Aldrich N, Gerstenblith M, Fu P, Tuttle MS, Varma P, Gotow E, Cooper KD, Mann M, Popkin DL (2015) Genetic vs Environmental Factors That Correlate With Rosacea: A Cohort-Based Survey of Twins. JAMA Dermatol. 151(11):1213-9

    Article  Google Scholar 

  • Allen KJ, Davis CL, Billings SD, Mousdicas N (2007) Recalcitrant papulopustular rosacea in an immunocompetent patient responding to combination therapy with oral ivermectin and topical permethrin. Cutis 80(2):149-51

    Google Scholar 

  • Altinyazar HC, Koca R, Tekin NS, Esturk E (2005) Adapalene vs. metronidazole gel for the treatment of rosacea. Int J Dermatol 44: 252-255

    Article  CAS  Google Scholar 

  • Alvarez-Elcoro S, Enzler MJ (1999) The macrolides: erythromycin, clarithromycin, and azithromycin. Mayo Clin Proc 74(6):613-34

    Article  CAS  Google Scholar 

  • Angermeier MC. Treatment of facial vascular lesions with intense pulsed light. J Cutan Laser Ther 1999;1(2):95-100

    Article  CAS  Google Scholar 

  • Baker B. Low-dose, pulsed oral isotretinoin may clear resistant Rosazea. Skin & Allergy News 1999;30(12):23

    Google Scholar 

  • Bartholomew RS, Reid BJ, Cheesbrough MJ, Macdonald M, Galloway NR. Oxytetracycline in the treatment of ocular Rosazea: a double-blind trial. Br J Ophthalmol 1982;66:386-8

    Article  CAS  Google Scholar 

  • Bernstein EF. Chemical peels. In: Hawke M, Franco KL, Dover JS, McNeill TW, et al, editors. Atlas of Cosmetic Surgery with DVD (2nd ed). Philadelphia, PA: Saunders; 2009; pp. 117-34

    Chapter  Google Scholar 

  • Borelli C, Becker B, Thude S, Fehrenbacher B, Isermann D (2017) Dermasence refining gel modulates pathogenetic factors of rosacea in vitro. J Cosmet Dermatol. 2017 Mar 27. doi: 10.1111/jocd.12323

    Article  CAS  Google Scholar 

  • Borelli C, Korting HC (2011) Nichtmedikamentöses Management der Rosazea. Hautarzt 62:828-833

    Article  CAS  Google Scholar 

  • Bormann G, Gaber G, Fischer M, Marsch WC (2001) Dapsone in rosacea fulminans. J Eur Acad Dermatol Venerol 15(5):465-7

    Article  CAS  Google Scholar 

  • Borrie P (1953) Rosacea with special reference to its ocular manifestations. Br J Dermatol 65: 458-63

    Article  CAS  Google Scholar 

  • Bostanci O, Borelli C, Schaller M (2010) Treatment of extrafacial rosacea with low-dose isotretinoin. Acta dermato-venerologica 90:409-410

    Article  Google Scholar 

  • Ci X, i H, Yu Q, Zhang X, Yu L, Chen N, Song Y, Deng X (2009). Avermectin exerts anti-inflammatory effect by downregulating the nuclear transcription factor kappa-B and mitogen-activated protein kinase activation pathway. Fundam Clin Pharmacol. 23(4):449-55

    Article  CAS  Google Scholar 

  • Coda AB, Hata T, Miller J, Audish D, Kotol P, Two A, Shafiq F, Yamasaki K, Harper JC, Del Rosso JQ, Gallo RL (2013) Cathelicidin, kallikrein 5, and serine protease activity is inhibited during treatment of rosacea with azelaic acid 15 % gel. J Am Acad Dermatol. 69(4):570-7

    Article  CAS  Google Scholar 

  • Coleman MD (1993) Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance. Br J Dermatol129(5):507-13

    Article  CAS  Google Scholar 

  • Crawford GH, Pelle MT, James WD. Rosazea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 2004;51:327-41

    Google Scholar 

  • Del Rosso JQ (2012) Advances in Understanding and Managing Rosacea: Part 2. The Central Role, Evaluation, and Medical Management of Diffuse and Persistent Facial Erythema of Rosacea. J Clin Aesthet Dermatol 5(3): 26-36

    Google Scholar 

  • Del Rosso JQ. Medical treatment of Rosazea with emphasis on topical therapies. Expert Opin Pharmacother 2004;5:5-13

    Google Scholar 

  • Diaz C, O’Callaghan C, Khan A, Ilchyshyn A. Rosazea: a cutaneous marker of Helicobacter pylori infection? Results of a pilot study. Acta Derm Venereol 2003;83:282-6

    Article  Google Scholar 

  • Ditre CM. Alpha-hydroxy acid peels. In: Tung RC, Rubin MG, editors. Procedures in Cosmetic Dermatology Series: Chemical Peels (2nd ed). Philadelphia, PA: Saunders; 2011; pp. 27-40

    Chapter  Google Scholar 

  • Erbagcaronci Z, Özgöztascedili O. The significance of Demodex folliculorum density in Rosazea. Int J Dermatol 1998;37(6):421-5

    Article  CAS  Google Scholar 

  • Erlt GA, Levine N, Kligman AM. A comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in Rosazea. Arch Dermatol 1994;130:319-24

    Article  CAS  Google Scholar 

  • Fernandez-Obregon A. Oral use of azithromycin for the treatment of acne Rosazea. Arch Dermatol 2004;140:489-90

    Google Scholar 

  • Forstinger C, Kittler H, Binder M (1999) Treatment of rosacea-like demodicidosis with oral ivermectin and topical permethrin cream. J Am Acad Dermatol 41(5 Pt 1):775-777

    Article  CAS  Google Scholar 

  • Forton F, Seys B (1993) Density of Demodex folliculorum in rosacea: a case-control study using standardized skin-surface biopsy. Br J Dermatol. 128(6):650-9

    Article  CAS  Google Scholar 

  • Forton F, Seys B, Marchal JL, Song AM (1998) Demodex folliculorum and topical treatment: acaricidal action evaluated by standardized skin surface biopsy. Br J Dermatol. 138(3):461-6

    Article  CAS  Google Scholar 

  • Forton FM, De Maertelaer V (2017) Two Consecutive Standardized Skin Surface Biopsies: An Improved Sampling Method to Evaluate Demodex Density as a Diagnostic Tool for Rosacea and Demodicosis. Acta Derm Venereol. 97(2):242-248

    Article  Google Scholar 

  • Fowler J Jr, Jackson M, Moore A, Jarratt M, Jones T, Meadows K, Steinhoff M, Rudisill D, Leoni M (2013) Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5 % for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies. J Drugs Dermatol. 12(6): 650-6

    Google Scholar 

  • Fowler J, Jarratt M, Moore A, Meadows K, Pollack A, Steinhoff M, Liu Y, Leoni M (2012) Brimonidine Phase II Study Group.Once-daily topical brimonidine tartrate gel 0•5 % is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies. Br J Dermatol. 166(3):633-41

    Google Scholar 

  • Gollnick H, Blume-Peytavi U, Szabó EL, Meyer KG, Hauptmann P, Popp G, Sebastian M, Zwingers T, Willers C, von der Weth R (2010) Systemic isotretinoin in the treatment of rosacea - doxycycline- and placebo-controlled, randomized clinical study. J Dtsch Dermatol Ges 8(7):505-15

    PubMed  Google Scholar 

  • Gonser LI, Gonser CE, Deuter C, Heister M, Zierhut M, Schaller M (2017) Systemic therapy of ocular and cutaneous rosacea in children. J Eur Acad Dermatol Venereol. doi: 10.1111/jdv.14402. [Epub ahead of print]

    Article  CAS  Google Scholar 

  • Hsu CC, Lee JY. (2012) Pronounced facial flushing and persistent erythema of rosacea effectively treated by carvedilol, a nonselective β-adrenergic blocker. J Am Acad Dermatol. 67(3):491-3

    Google Scholar 

  • Ilkovitch D, Pomerantz RG (2014) Brimonidine effective but may lead to significant rebound erythema. J Am Acad Dermatol. 70(5):e109-10

    Article  Google Scholar 

  • Jansen T, Plewig G. (1998) Clinical and histological variants of rhinophyma, including nonsurgical treatment modalities. Facial Plast Surg. 14(4): 241-53

    Article  CAS  Google Scholar 

  • Karow T, Lang-Roth R (Hrsg) (2014) Allgemeine und spezielle Pharmakologie und Toxikologie: vorlesungsorientierte Darstellung und klinischer Leitfaden für Studium und Praxis 2015. 23. Auflage. Pulheim

    Google Scholar 

  • Krause MH, Torricelli R, Kündig T, Trüeb RM, Hafner J (1997) Dapson bei granulomatöser Rosazea. Hautarzt 48(4):246-8

    Google Scholar 

  • Kresken J, Kindl U, Wigger-Alberti W (2015) Dermokosmetika zur Anwendung bei Rosazea. Leitlinie der GD Gesellschaft für Dermopharmazie e.V. Köln

    Google Scholar 

  • Laquieze S, Czernielewski J, Baltas E (2007) Beneficial use of Cetaphil moisturizing cream as part of a daily skin care regimen for individuals with rosacea. Dermatolog Treat. 18(3):158-62

    Article  CAS  Google Scholar 

  • Layton A, Thiboutot D (2013) Emerging therapies in rosacea. J Am Acad Dermatol. 69(6 Suppl 1):57-65

    Article  CAS  Google Scholar 

  • Layton AM, Schaller M, Homey B, Hofmann MA, Bewley AP, Lehmann P, Nohlgård C, Sarwer DB, Kerrouche N, Ma YM (2015) Brimonidine gel 0.33 % rapidly improves patient-reported outcomes by controlling facial erythema of rosacea: a randomized, double-blind, vehicle-controlled study. J Eur Acad Dermatol Venereol. 29(12):2405-10

    Article  CAS  Google Scholar 

  • Lebrun-Vignes B, Kreft-Jais C, Castot A, Chosidow O (2012) Comparative analysis of adverse drug reactions to tetracyclines: results of a French national survey and review of the literature. Br J Dermatol 166(6):1333-41

    Article  CAS  Google Scholar 

  • Levin J, Miller R (2011) A Guide to the Ingredients and Potential Benefits of Over-the-Counter Cleansers and Moisturizers for Rosacea Patients. J Clin Aesthet Dermatol. 4(8):31-49

    Google Scholar 

  • Litt JZ. Steroid-induced Rosazea. Am Fam Physician 1993;48:67-71

    Google Scholar 

  • Madsen JT, Thormann J, Kerre S, Andersen KE, Goossens A (2007) Allergic contact dermatitis to topical metronidazole – 3 cases. Contact Dermatitis 56: 364-366

    Article  Google Scholar 

  • Mark KA, Sparacio RM, Voigt A, Marenus K, Sarnoff DS. Objective and Quantitative Improvement of Rosazea-Associated Erythema After Intense Pulsed Light Treatment. Dermatologic Surgery 2003;29(6):600-4

    PubMed  Google Scholar 

  • Melnik B, Jansen T. (2012) Akne und Rosazea. In: Plewig G, Landthaler M, Burgdorf W et al. (Hrsg) Dermatologie und Venerologie. 6. Auflage. Springer Verlag, Berlin, S 1197-1229

    Chapter  Google Scholar 

  • Moore A, Kempers S, Murakawa G, Weiss J, Tauscher A, Swinyer L, Liu H, Leoni M. (2014) Long-term safety and efficacy of once-daily topical brimonidine tartrate gel 0.5 % for the treatment of moderate to severe facial erythema of rosacea: results of a 1-year open-label study. J Drugs Dermatol. 13(1):56-61

    Google Scholar 

  • Moustafa F, Lewallen RS, Feldman SR (2014) The psychological impact of rosacea and the influence of current management options. J Am Acad Dermatol. 71(5):973-80

    Article  Google Scholar 

  • Nase G, PhD. Latest Advances: Triple-pass laser tx. Dermatology Times, 1 March 2005 Issue

    Google Scholar 

  • Park H, Del Rosso JQ (2011) Use of oral isotretinoin in the management of rosacea. J Clin Aesthet Dermatol 4(9):54-61

    Google Scholar 

  • Pelle MT, Crawford GH, James WD. Rosazea: II. Therapy. J Am Acad Dermatol 2004;51:499-512

    Google Scholar 

  • Pfeffer I, Borelli C, Zierhut M, Schaller M (2011) Treatment of ocular rosacea with 40 mg doxycycline in a slow release form. J Dtsch Dermatol Ges 9(11):904-907

    PubMed  Google Scholar 

  • Piwnica D, Rosignoli C, de Ménonville ST, Alvarez T, Schuppli Nollet M, Roye O, Jomard A, Aubert J (2014) Vasoconstriction and anti-inflammatory properties of the selective α-adrenergic receptor agonist brimonidine. J Dermatol Sci. 75(1):49-54

    Article  CAS  Google Scholar 

  • Powell FC. Rosazea. N Engl JMed 2005;352:793-803

    Google Scholar 

  • Powell FC. The histopathology of Rosazea: ‘where’s the beef’? Dermatology 2004;209:173-4

    Article  Google Scholar 

  • Pye RJ, Burton JL (1976) Treatment of rosacea by metronidazole. Lancet 5;1:1211-2

    Article  Google Scholar 

  • Quarterman MJ, Johnson DW, Abele DC, Lesher JL Jr, Hull DS, Davis LS (1997) Ocular rosacea. Signs, symptoms, and tear studies before and after treatment with doxycycline. Arch Dermatol. 133(1):49-54

    Google Scholar 

  • Quarterman MJ, Johnson DW, Abele DC, Lesher JL Jr, Hull DS, Davis LS. Ocular Rosazea: signs, symptoms, and tear studies before and after treatment with doxy¬cycline. Arch Dermatol 1997;133:49-54

    Google Scholar 

  • Ramelet AA. Rosazea: a reaction pattern associated with ocular lesions and migraine? Arch Dermatol 1994;130:1448

    Article  CAS  Google Scholar 

  • Raulin C, Greve B, Grema H. IPL technology: A review. Lasers Surg Med 2003;32(2):78-87

    Google Scholar 

  • Reinholz M, Ruzicka T, Schauber J. (2012) Cathelicidin LL-37: an antimicrobial peptide with a role in inflammatory skin disease. Ann Dermatol. 2012 May;24(2):126-35

    Article  CAS  Google Scholar 

  • Reinholz M, Ruzicka T, Steinhoff M, Schaller M, Gieler U, Schöfer H, Homey B, Lehmann P, Luger TA (2016) Pathogenese und Klinik der Rosazea als Schlüssel für eine symptomorientierte Therapie. J Dtsch Dermatol Ges. 2016 Dec;14 Suppl 6:4-16

    PubMed  Google Scholar 

  • Reinholz M, Tietze JK, Kilian K, Schaller M, Schöfer H, Lehmann P, Zierhut M, Klövekorn W, Ruzicka T, Schauber J (2013) Rosacea - S1 guideline. J Dtsch Dermatol Ges. 11(8):768-80

    PubMed  Google Scholar 

  • Reserva J1, Champlain A, Soon SL, Tung R Dermatol Surg. 2017 Sep 4. doi: 10.1097/DSS.0000000000001281. [Epub ahead of print] Chemical Peels: Indications and Special Considerations for the Male Patient

    Article  CAS  Google Scholar 

  • Rodriguez-Martinez S, Cancino-Diaz JC, Vargas-Zuniga LM, Cancino-Diaz ME (2008) LL-37 regulates the overexpression of vascular endothelial growth factor (VEGF) and c-IAP-2 in human keratinocytes. Int J Dermatol. 47: 457-62

    Article  Google Scholar 

  • Rote Liste (2017), Frankfurt/Main

    Google Scholar 

  • Routt ET, Levitt JO (2014) Rebound erythema and burning sensation from a new topical brimonidine tartrate gel 0.33 %. J Am Acad Dermatol. 70(2):e37-8

    Article  Google Scholar 

  • Sapadin AN, Fleischmajer R (2006) Tetracyclines: Nonantibiotic properties and their clinical implications. J Am Acad Dermatol 54:258-65

    Article  Google Scholar 

  • Schaller M, Almeida LM, Bewley A, Cribier B, Dlova NC, Kautz G, Mannis M, Oon HH, Rajagopalan M, Steinhoff M, Thiboutot D, Troielli P, Webster G, Wu Y, van Zuuren E, Tan J (2017 A) Rosacea treatment update: recommendations from the global ROSacea COnsensus (ROSCO) panel. Br J Dermatol.176(2):465-471

    Article  CAS  Google Scholar 

  • Schaller M, Dirschka T, Kemény L, Briantais P, Jacovella J (2016C). Superior Efficacy with Ivermectin 1 % Cream Compared to Metronidazole 0.75 % Cream Contributes to a Better Quality of Life in Patients with Severe Papulopustular Rosacea: A Subanalysis of the Randomized, Investigator-Blinded ATTRACT Study. Dermatol Ther (Heidelb) 6(3):427-36

    Article  Google Scholar 

  • Schaller M, Gonser L, Belge K, Braunsdorf C, Nordin R, Scheu A, Borelli C (2017 B) Dual anti-inflammatory and antiparasitic action of topical ivermectin 1 % in papulopustular rosacea. J Eur Acad Dermatol Venereol. doi: 10.1111/jdv.14437. [Epub ahead of print]

    Article  CAS  Google Scholar 

  • Schaller M, Sander CA, Plewig G (2003) Demodex abscesses: clinical and therapeutic challenges. J Am Acad Dermatol 49(5 Suppl):272-4

    Article  Google Scholar 

  • Schaller M, Schöfer H, Homey B, Gieler U, Lehmann P, Luger TA, Ruzicka T, Steinhoff M (2016B) Aktueller Stand der systemischen Rosazea-Therapie. J Dtsch Dermatol Ges. 2016 Dec;14 Suppl 6:29-37

    PubMed  Google Scholar 

  • Schaller M, Schöfer H, Homey B, Hofmann M, Gieler U, Lehmann P, Luger TA, Ruzicka T, Steinhoff M (2016 A) Rosazea-Management: Update über allgemeine Maßnahmen und topische Therapieoptionen. J Dtsch Dermatol Ges. 2016 Dec;14 Suppl 6:17-28

    PubMed  Google Scholar 

  • Schroeter CA, Haaf-von Below S, Neumann HA. Effective treatment of Rosazea using intense pulsed light systems. Dermatol Surg 2005;31(10):1285-9

    Article  CAS  Google Scholar 

  • Seité S, Benech F, Berdah S, Bayer M, Veyrat S, Segot E, Sakalikova M, Gibejova L, Zelenkova H (2013) Management of rosacea-prone skin – Evaluation of a skin care product containing Ambophenol, Neurosensine, and La Roche- Posay thermal spring water as monotherapy or adjunctive therapy. J Drugs Dermatol 8:920-924

    Google Scholar 

  • Smith JR, Lanier VB, Braziel RM, Falkenhagen KM, White C, Rosenbaum JT. Expression of vascular endothelial growth factor and its receptors in Rosazea. Br J Ophthalmol 2007;91:226-9

    Article  Google Scholar 

  • Sobolewska B, Doycheva D, Deuter C, Pfeffer I, Schaller M, Zierhut M (2014) Treatment of ocular rosacea with once-daily low-dose doxycycline. Cornea 33(3):257-60

    Article  Google Scholar 

  • Sobottka A, Lehmann P (2009) Rosazea 2009. Neue Erkenntnisse zur Pathophysiologie, klinische Manifestationsformen und Therapiestrategien. Hautarzt 60: 999-1009

    Article  CAS  Google Scholar 

  • Sobye P. Treatment of Rosazea by massage. Acta Derm Venereol 1951;31:174-83

    Google Scholar 

  • Spoendlin J, Voegel JJ, Jick SS, Meier CR (2012) A study on the epidemiology of rosacea in the U.K.Br J Dermatol. 167(3):598-605

    Article  CAS  Google Scholar 

  • Stein L, Kircik L, Fowler J, Tan J, Draelos Z, Fleischer A, Appell M, Steinhoff M, Lynde C, Liu H, Jacovella J (2014) Efficacy and safety of ivermectin 1 % cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies. J Drugs Dermatol. 13(3):316-23

    Google Scholar 

  • Steinhoff M, Schauber J, Leyden JJ.J (2013) New insights into rosacea pathophysiology: a review of recent findings. Am Acad Dermatol. 2013 Dec;69 (6 Suppl 1):15-26

    Article  CAS  Google Scholar 

  • Sugarman JH, Fleischer AB Jr, Feldman SR. Off-label prescribing in the treatment of dermatologic disease. J Am Acad Dermatol 2002;47:217-23

    Article  Google Scholar 

  • Taieb A, Khemis A, Ruzicka T, Baranska-Rybak W, Berth-Jones J, Schauber J, Briantais P, Jacovella J, Passeron T (2015 B) Maintenance of remission following successful treatment of papulopustular rosacea with ivermectin 1 % cream vs. metronidazole 0.75 % cream: 36-week extension of the ATTRACT randomized study. J Eur Acad Dermatol Venereol.;30(5):829-36

    Article  Google Scholar 

  • Taieb A, Ortonne JP, Ruzicka T, Roszkiewicz J, Berth-Jones J, Peirone MH, Jacovella J (2015 A) Superiority of ivermectin 1 % cream over metronidazole 0.75 % cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial.Br J Dermatol. 172(4):1103-10

    Article  CAS  Google Scholar 

  • Tan J, Almeida LM, Bewley A, Cribier B, Dlova NC, Gallo R, Kautz G, Mannis M, Oon HH, Rajagopalan M, Steinhoff M, Thiboutot D, Troielli P, Webster G, Wu Y, van Zuuren EJ, Schaller M (2017) Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel. Br J Dermatol 176(2):431-438

    Article  CAS  Google Scholar 

  • Tan J, Schöfer H, Araviiskaia E, Audibert F, Kerrouche N, Berg M (2016) Prevalence of rosacea in the general population of Germany and Russia – The RISE study. J Eur Acad Dermatol Venereol. 30(3):428-34

    Article  CAS  Google Scholar 

  • Tan R, Tope WD. Pulsed dye laser treatment of Rosazea improves erythema, symptomology, and quality of life. J Am Acad Dermatol 2004;51:592-9

    Article  Google Scholar 

  • van Zuuren EJ, Fedorowicz Z (2015) Interventions for rosacea: abridged updated Cochrane systematic review including GRADE assessments. Br J Dermatol. 173(3):651-62

    Article  CAS  Google Scholar 

  • Vienne MP, Ochanda N, Borrel MT, Gall Y, Lauze C, Dupuy P (1999) Retinaldehyde alleviates rosacea. Dermatology 199, Suppl. 1, 53-56

    Article  CAS  Google Scholar 

  • Weber TM, Ceilley RI, Buerger A, Kolbe L, Trookman NS, Rizer RL, Schoelermann A (2006) Skin tolerance, efficacy, and quality of life of patients with red facial skin using a skin care regimen containing licochalcone A. J Cosmet Dermatol 5:227-232

    Article  CAS  Google Scholar 

  • Webster G, Schaller M, Tan J, Jackson JM, Kerrouche N, Schäfer G (2017) Defining treatment success in rosacea as ‘clear’ may provide multiple patient benefits: results of a pooled analysis. J Dermatolog Treat 28(5):469-474

    Article  Google Scholar 

  • Wilkin J, Dahl M, Detmar M, Drake L, Liang MH, Odom R, Powell F. Standard grading system for Rosazea: report of the National Rosazea Society Expert Committee on the classification and staging of Rosazea. J Am Acad Dermatol 2004;50:907-12

    Article  Google Scholar 

  • Wilkin JK. Effect of nadolol on flushing reactions in Rosazea. J Am Acad Dermatol 1989;20:202-5

    Article  CAS  Google Scholar 

  • Wu JJ, Weinstein GD, Kricorian GJ, Kormeili T, McCullough JL (2007) Topical kinetin 0.1 % lotion for improving the signs and symptoms of rosacea. Clin Exp Dermatol 32:693-695

    Article  CAS  Google Scholar 

  • Yamasaki K, Di Nardo A, Bardan A, Murakami M, Ohtake T, Coda A, Dorschner RA, Bonnart C, Descargues P, Hovnanian A, Morhenn VB, Gallo RL (2007) Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med. 13: 975-80

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsklinikum Tübingen, Universitäts-Hautklinik, Tübingen, Deutschland

    Dr. K. Belge & Prof. Dr. C. Borelli

  2. Haut- und Laserklinik, Konz, Deutschland

    Dr. G. Kautz & Dr. I. Kautz

Authors
  1. Dr. K. Belge
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. C. Borelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dr. G. Kautz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dr. I. Kautz
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hautarztpraxis, Konz, Deutschland

    Gerd Kautz

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Cite this chapter

Belge, K., Borelli, C., Kautz, G., Kautz, I. (2018). Topische und systemische Therapie der Rosazea. In: Kautz, G. (eds) Energie für die Haut. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-56436-3_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-56436-3_21

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-56435-6

  • Online ISBN: 978-3-662-56436-3

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation